Regeneron Pharmaceuticals
REGN
REGN
1,015 hedge funds and large institutions have $54.3B invested in Regeneron Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 132 funds opening new positions, 406 increasing their positions, 328 reducing their positions, and 73 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.94% more ownership
Funds ownership: 85.01% → 85.95% (+0.94%)
6% less funds holding in top 10
Funds holding in top 10: 18 → 17 (-1)
20% less call options, than puts
Call options by funds: $1.16B | Put options by funds: $1.44B
Holders
1,015
Holding in Top 10
17
Calls
$1.16B
Puts
$1.44B
Top Buyers
| 1 | +$251M | |
| 2 | +$207M | |
| 3 | +$195M | |
| 4 |
Amundi
Paris,
France
|
+$140M |
| 5 |
SGH
Sivik Global Healthcare
Greenwich,
Connecticut
|
+$99.3M |
Top Sellers
| 1 | -$428M | |
| 2 | -$235M | |
| 3 | -$177M | |
| 4 |
Neuberger Berman Group
New York
|
-$108M |
| 5 |
HM
HealthCor Management
New York
|
-$106M |